Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model

Behavioural Pharmacology

Volumn 15, Issue 5-6, 2004, Pages 341-352

  Adriani, W ^a   Laviola, G ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

ADHD; Adolescence; Animal models; Drug dependence; Methylphenidate cannabinoids; Nicotine; Risky behaviour

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPHETAMINE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CHOLINERGIC RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DRONABINOL; KAPPA OPIATE RECEPTOR; METHYLPHENIDATE; NICOTINE; PSYCHOTROPIC AGENT;

ADDICTION; ATTENTION DEFICIT DISORDER; BEHAVIOR; CORPUS STRIATUM; DEVELOPMENTAL STAGE; DOWN REGULATION; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG EXPOSURE; DRUG SELF ADMINISTRATION; HUMAN; HYPERTENSION; IMPULSIVENESS; INSTRUMENTAL CONDITIONING; MENTAL DISEASE; MENTAL STRESS; NERVE CELL PLASTICITY; NEUROPSYCHIATRY; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; REVIEW; SELF CONTROL;

EID: 4544256595     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200409000-00005     Document Type: Review

References (138)

1. Abrous DN, Adriani W, Montaron MF, Aurousseau C, Rougon G, Le Moal M, Piazza PV (2002). Nicotine self-administration impairs hippocampal plasticity. J Neurosci 22:3656-3662.
2. Adriani W, Laviola G (2000). A unique profile of behavioral and hormonal hyporesponsivity in periadolescent mice. Neuropharmacology 39:334-346.
3. Adriani W, Laviola G (2002). Spontaneous novelty seeking and amphetamine-induced conditioning and sensitization in adult mice. Evidence of dissociation as a function of age at weaning. Neuropsychopharmacology 27:225-236.
4. Adriani W, Laviola G (2003). Elevated levels of impulsivity and reduced place conditioning with D-amphetamine: Two behavioral features of adolescence in mice. Behav Neurosci 117:695-703.
5. Adriani W, Chiarotti F, Laviola G (1998). Elevated novelty seeking and peculiar D-amphetamine sensitization in periadolescent mice compared to adult mice. Behav Neurosci 112:1152-1166.
6. Adriani W, Spijker S, Deroche-Gamonet V, Laviola G, Le Moal M, Smit AB, Piazza PV (2003a). Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J Neurosci 23:4712-4716.
7. Adriani W, Caprioli A, Granstrem O, Carli M, Laviola G (2003b). The spontaneously-hypertensive-rat as an animal model of ADHD: Evidence for impulsive and non-impulsive subpopulations. Neurosci Biobehav Rev 27:639-651.
8. Adriani W, Granstrem O, Macri' S, Izykenova G, Dambinova S, Laviola G (2004a). Behavioral and neurochemical vuinerability during adolescence in mice: Studies with spontaneous consumption or imposed administration of nicotine. Neuropsychopharmacology (in press).
9. Adriani W, Rea M, Baviera M, Invernizzi W, Carli M, Ghirardi O, et al. (2004b). Acetyl-L-carnitine reduces impulsive behaviour in adolescent rats. Psychopharmacology (Berl) (in press).
10. Andersen SL (2003). Trajectories of brain development: Points of vulnerability or windows of opportunity? Neurosci Biobehav Rev 27:3-18.
11. Anthony JC, Petronis KR (1995). Early-onset drug use and risk of later drug problems. Drug Alcohol Depend 40:9-15.
12. Arnett J (1992). Reckless behavior in adolescence: A developmental perspective. Dev Rev 12:339-373.
13. Belluzzi JD, Lee AG, Oliff HS, Leslie FM (2004). Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology (Berl) (in press).
14. Beltramo M, Rodriguez de Fonseca F, Navarro M, Calignano A, Gorriti MA, Grammatikopoulos G, et al. (2000). Reversal of dopamine D2 receptor responses by an anandamide transport inhibitor. J Neurosci 20:3401-3407.
15. Biscaia M, Marin S, Fernandez B, Marco EM, Rubio M, Guaza C, et al. (2003). Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood. Psychopharmacology (Berl) 170:301-308.
16. Bizot J, Le Bihan C, Puech AJ, Hamon M, Thiebot M (1999). Serotonin and tolerance to delay of reward in rats. Psychopharmacology (Berl) 146:400-412.
17. Breslau N, Peterson EL (1996). Smoking cessation in young adults: Age at initiation of cigarette smoking and other suspected influences. Am J Public Health 86:214-220.
18. Calcagnetti DJ, Schechter MD (1994). Nicotine place preference using the biased method of conditioning. Prog Neuropharmacol Biol Psychiatry 18:925-933.
19. Casey BJ, Giedd JN, Thomas KM (2000). Structural and functional brain development and its relation to cognitive development. Biol Psychol 54:241-157.
20. Castellanos FX, Elia J, Kruesi MJP, Gulotta CS, Mefford IN, Potter WZ, et al. (1994). Cerebrospinal fluid monoamine metabolites in boys with attention deficit hyperactivity disorder. Psychiatry Res 52:305-316.
21. Chambers RA, Taylor JR, Potenza MN (2003). Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. Am J Psychiatry 160:1041-1052.
22. Chechik G, Meilijson I, Ruppin E (1999). Neuronal regulation: A mechanism for synaptic pruning during brain maturation. Neural Comput 11:2061-2080.
23. Chaperon F, Soubrié P, Puech AJ, Thiebot MH (1998). Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology (Berl) 135:324-332.
24. Cheer JF, Cadogan AK, Marsden CA, Fone KC, Kendall DA (1999). Modification of 5-HT2 receptor mediated behavior in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology 38:533-541.
25. Cheer JF, Kendall DA, Marsden CA (2000). Cannabinoid receptors and reward in the rat: a conditioned place preference study. Psychopharmacology (Berl) 151:25-30.
26. Chugani HT, Phelps ME, Mazziotta JC (1987). Positron emission tomography study of human brain functional development. Ann Neurol 22:487-497.
27. Clark DB, Kirisci L, Tarter RE (1998). Adolescent versus adult onset and the development of substance use disorders in males. Drug Alcohol Depend 49:115-121.
28. Clarke PBS, Fu DS, Jakubovic A, Fibiger HC (1988). Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther 246:701-708.
29. Coccaro EF, Kavoussi RJ, Sheline YI, Bermann ME, Csernansky JG (1997). Impulsive aggression in personality disorder correlates with platelet 5-HT(2A) receptor binding. Neuropsychopharmacology 16:211-216.
30. Colby SM, Tiffany ST, Shiffman S, Niaura RS (2000). Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend 59(suppl 1):83-95.
31. Corrigall WA, Franklin KBJ, Coen KM, Clarke PBS (1992). The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107:285-289.
32. Corrigall WA, Coen KM, Adamson KL (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284.
33. 2+ dependent mechanism. Neuropharmacology 39:2799-2807.
34. Dalley JW, Theobald DE, Eagle DM, Passetti F, Robbins TW (2002). Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 26:716-728.
35. Darmani NA (2001). Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice. Pharmacol Biochem Behav 68:311-317.
36. Darmani NA, Pandya DK (2000). Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR141716A in naive mice. J Neural Transm 107:931-945.
37. De Bellis MD, Keshavan MS, Beers SR, Hall J, Frustaci K, Masalehdan A, et al. (2001). Sex differences in brain maturation during childhood and adolescence. Cereb Cortex 11:552-557.
38. DiCiano P, Everitt BJ (2001). Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 25:341-360.
39. DiCiano P, Cardinal RN, Cowell RA, Little SJ, Everitt BJ (2001). Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior. J Neurosci 21:9471-9477.
40. Eissenberg T, Balster RL (2000). Initial tobacco use episodes in children and adolescents: current knowledge, future directions. Drug Alcohol Depend 59(suppl 1):41-60.
41. Evenden JL, Ryan CN (1996). The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl) 128:161-170.
42. Evenden JL, Ryan CN (1999). The pharmacology of impulsive behaviour in rats VI: the effects of ethanol and selective serotonergic drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl) 146:413-421.
43. Faraday MM, Elliott BM, Grunberg NE (2001). Adult vs. adolescent rats differ in biobehavioral responses to chronic nicotine administration. Pharmacol Biochem Behav 70:475-489.
44. Fasano S, Brambilla R (2002). Cellular mechanisms of striatum-dependent behavioral plasticity and drug addiction. Curr Mol Med 2:649-665.
45. Fattore L, Cossu G, Martellotta CM, Fratta W (2001). Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology (Berl) 156:410-416.
46. Ferrari F, Ottani A, Giuliani D (1999). Influence of the cannabinoid agonist HU-210 on cocaine- and CQP-201-403-induced behavioral effects in rats. Life Sci 65:823-831.
47. Fudala PJ, Teoh KW, Iwamoto ET (1985). Pharmacologic characterization of nicotine-induced conditioned place preference. Pharmacol Biochem Behav 22:237-241.
48. Gardner EL (2002). Addictive potential of cannabinoids: the underlying neurobiology. Chem Priys Lipids 121:267-290.
49. Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM (2003). It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 26:184-192.
50. Gessa GL, Melis M, Muntoni AL, Diana M (1998). Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 341:39-44.
51. Ghozland S, Matthes HW, Simonin F, Filliol D, Kieffer BL, Maldonado R (2002). Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci 22:1146-1154.
52. Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D (1999). Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358-363.
53. Glick SD, Milloy S (1973). Rate-dependent effects of D-amphetamine on locomotor activity in mice: Possible relationship to paradoxical amphetamine sedation in minimal brain dysfunctions. Eur J Pharmacol 24:266-268.
54. Hayase T, Yamamoto Y, Yamamoto K (2001). Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioral symptoms. J Pharm Pharmacol 53:1525-1532.
55. Henningfield JE, Miyasato K, Jasinski DR (1983). Cigarette smokers self-administer intravenous nicotine. Pharmacol Biochem Behav 19:887-890.
56. Henningfield JE, Miyasato K, Jasinski DR (1985). Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234:1-12.
57. Hermann H, Marsicano G, Lutz B (2002). Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal sub-populations of the adult mouse forebrain. Neuroscience 109:451-460.
58. Johansen EB, Aase H, Meyer A, Sagvolden T (2002). Attention deficit hyperactivity disorder (ADHD) behaviour explained by dysfunctioning reinforcement and extinction processes. Behav Brain Res 130:37-45.
59. Justinova Z, Tanda G, Redhi GH, Goldberg SR (2003). Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology (Berl) 169:135-140.
60. Kellogg CK, Awatramani GB, Piekut DT (1998). Adolescent development alters stressor-induced FOS immunoreactivity in rat brain. Neuroscience 83:681-689.
61. Klein LC, Stine MM, Pfaff DW, Vandenbergh DJ (2003). Maternal nicotine exposure increases nicotine preference in periadolescent male but not female C57B1/6J mice. Nicotine Tob Res 5:117-124.
62. Kuczenski R, Segal DS (2002). Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22:7264-7271.
63. Kuczenski R, Segal DS, Leith NJ, Applegate CD (1987). Effects of amphetamine, methylphenidate, and apomorphine on regional brain serotonin and 5-hydroxyindole acetic acid. Psychopharmacology (Berl) 93:329-335.
64. Laviola G, Adriani W, Morley-Fletcher S, Terranova L (2002). Peculiar response of adolescent mice to acute and chronic stress and to amphetamine: evidence of sex differences. Behav Brain Res 130:117-125.
65. Laviola G, Macri' S, Morley-Fletcher S, Adriani W (2003). Risk-taking behavior in adolescent mice: Psychobiological determinants and early epigenetic influence. Neurosci Biobehav Rev 27:19-31.
66. Laviola G, Adriani W, Rea M, Aloe L, Alleva E (2004). Social withdrawal, neophobia, and stereotyped behavior in developing rats exposed to neonatal asphyxia. Psychopharmacology (Berl) (in press).
67. Lidow MS, Goldman-Rakic PS, Rakic P (1991). Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc Natl Acad Sci USA 88:10218-10221.
68. Linnoila M, Virkkunen M, Schenin M, Nutila A, Rimon R, Goodwin FK (1983). Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci 33:2609-2614.
69. Logue AW, Tobin H, Chelonis JJ, Wang RY, Geary N, Schachter S (1992). Cocaine decreases the self-control in rats: A preliminary report. Psychopharmacology (Berl) 109:245-247.
70. Macri S, Laviola G (2004). Single episode of maternal deprivation and adult depressive profile in mice: Interaction with cannabinoid exposure during adolescence. Behav Brain Res (in press).
71. Macri S, Adriani W, Chiarotti F, Laviola G (2002). Risk-taking during exploration of a plus-maze is greater in adolescent than in juvenile or adult mice. Anim Behav 64:541-546.
72. Mansvelder HD, McGehee D (2002). Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 53:606-617.
73. Masserano JM, Karoum F, Wyatt RJ (1999). SR141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine. Behav Pharmacol 10:429-432.
74. Mathias R (1996). Students' use of marijuana, other illicit drugs, and cigarettes continued to rise in 1995. NIDA Res Monogr 11:8-9.
75. May JC, Delgado MR, Dahl RE, Stenger VA, Ryan ND, Fiez JA, Carter CS (2004). Event-related functional magnetic resonance imaging of reward-related brain circuitry in children and adolescents. Biol Psychiatry 55:359-366.
76. Merlo-Pich E, Pagliusi SR, Tessari M, Talabot-Ayer D, Hooft van Huijsduijnen R, Chiamulera C (1997). Common neural substrates for the addictive properties of nicotine and cocaine. Science 275:83-86.
77. Meyer EL, Gahring LC, Rogers SW (2002). Nicotine preconditioning antagonizes activity-dependent caspase proteolysis of a glutamate receptor. J Biol Chem 277:10869-10875.
78. Nestler EJ (2001). Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119-128.
79. Nestler EJ (2002). Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem 78:637-647.
80. Nides MA, Rakos RF, Gonzales D, Murray RP, Tashkin DP, Bjornson-Benson W, et al. (1995). Predictors of initial smoking cessation and relapse through the first two years of the Lung Health Study. J Consult Clin Psychol 63:60-69.
81. Oades RD (2002). Dopamine may be 'hyper' with respect to noradrenaline metabolism, but 'hypo' with respect to serotonin metabolism, in children with attention-deficit hyperactivity disorder. Behav Brain Res 130:97-102.
82. Odell WD (1990). Sexual maturation in the rat. In: Grumbach (editor): Control of the onset of puberty. London: Williams and Wilkins; pp. 183-210.
83. Panagis G, Nisell M, Nomikos GG, Chergui K, Svensson TH (1996). Nicotine injections into the ventral tegmental area increase locomotion and FOS-like immunoreactivity in the nucleus accumbens of the rat. Brain Res 730:133-142.
84. Papa M, Diewald L, Carey MP, Esposito FJ, Carnevale UA, Sadile AG (2002). A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo- and a posterior hyperfunctioning meso-corticolimbic system. Behav Brain Res 130:171-179.
85. Paus T, Zijdenbos A, Worsley K, Collins DL, Blumenthal J, Giedd JN, et al. (1999). Structural maturation of neural pathways in children and adolescents: in vivo study. Science 283:1908-1911.
86. Piazza PV, Le Moal M (1998). The role of stress in drug self-administration. Trends Pharmacol Sci 19:67-74.
87. Piazza PV, Le Moal M (1996). Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36:359-378.
88. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, et al. (1998). Acetylcholine receptors containing the beta 2 subunit are involved in the reinforcing properties of nicotine. Nature 391:173-177.
89. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996). Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255-257.
90. Pontieri FE, Conti G, Zocchi A, Fieschi C, Orzi F (1999). Metabolic mapping of the effects of Win 55212-2 intravenous administration in the rat. Neuropsychopharmacology 21:773-776.
91. Prendergast MA, Harris BR, Mayer S, Holey RC, Hauser KF, Littleton JM (2001). Chronic nicotine exposure reduces NMDA receptor-mediated damage in the hippocampus without altering calcium accumulation or extrusion: evidence of calbindin-D28K overexpression. Neuroscience 102:75-85.
92. Preuss UW, Koller G, Bondy B, Bahlmann M, Soyka M (2001). Impulsive traits and 5-HT(2A) receptor promoter polymorphism in alcohol dependents: Possible association but no influence in personality disorders. Neuropsychobiology 43:186-191.
93. Puumala T, Sirvio J (1998). Changes in activity of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task. Neuroscience 83:489-499.
94. Reavill C, Stolerman IP (1990). Locomotor activity in rats after administration of nicotinic agonists intracerebrally. Br J Pharmacol 99:273-278.
95. Richards JB, Sabol KE, De Wit H (1999a). Effects of metamphetamine on the adjusting amount procedure, a model of impulsive behaviour in rats. Psychopharmacology (Berl) 146:432-439.
96. Risner ME, Goldberg SR (1983). A comparison of nicotine and cocaine self-administration in the dog: Fixed-ratio and progressive-ratio schedules of intravenous drug infusion. J Pharmacol Exp Ther 224:319-326.
97. Robbe D, Alonso G, Manzoni OJ (2003). Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens. Ann N Y Acad Sci 1003:212-225.
98. Robbins TW, Everitt BJ (2002). Limbic-striatal memory systems and drug addiction. Neurobiol Learn Mem 78:625-636.
99. Robins LN, Przybeck TR (1985). Age of onset of drug use as a factor in drug and other disorders.
100. Jones CL, Battjes RL (1991). Etiology of Drug Abuse: Implications for Prevention. NIDA Res Monogr 56:178-192.
101. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291.
102. Rose JE, Corrigall WA (1997). Nicotine self-administration in animals and humans: Similarities and differences. Psychopharmacology (Berl) 30:28-40.
103. Russell VA (2000). The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat as studied in vitro by the superfusion slice technique. Neurosci Biobehav Rev 24:133-136.
104. Sagvolden T (2000). Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24:31-39.
105. Sagvolden T, Johansen EB, Aase H, Russell VA (2004). A dynamic developmental theory of Attention-Deficit/Hyperactivity Disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci (in press).
106. Solanto MV (2002). Dopamine dysfunction in AD/HD: Integrating clinical and basic neuroscience research. Behav Brain Res 130:65-71.
107. Soubrié P (1986). Reconciling the role of central serotonin neurones in human and animal behavior. Behav Brain Sci 9:319-364.
108. Sowell ER, Thompson PM, Tessner KD, Toga AW (2001). Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: Inverse relationships during postadolescent brain maturation. J Neurosci 21:8819-8829.
109. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW (2003). Mapping cortical change across the human life span. Nat Neurosci 6:309-315.
110. Spealman RD, Goldberg SR (1982). Mainteinance of schedule-controlled behavior by intravenous injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther 223:402-408.
111. Spear LP (2000). The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463.
112. Spear LP, Brake SC (1983). Periadolescence: Age-dependent behavior and psycho-pharmacological responsivity in rats. Dev Psychobiol 16:83-109.
113. Stamford JA (1989). Development and ageing of the rat nigrostriatal dopamine system studied with fast cyclic voltammetry. J Neurochem 52:1582-1589.
114. Stolerman IP (1999). Inter-species consistency in the behavioural pharmacology of nicotine dependence. Behav Pharmacol 10:559-580.
115. Sutton MA, Schmidt EF, Chol KH, Schad CA, Whisler K, Simmons D, et al. (2003). Extinction-induced upregulation in AMPA receptots reduces cocaine-seeking behaviour. Nature 421:70-75.
116. Taioli E, Wynder EL (1991). The importance of age of starting smoking. New Engl J Med 325:968-969.
117. Tanda G, Goldberg SR (2003). Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacology (Berl) 169:115-134.
118. Tarazi FI, Tomasini EC, Baldessarini RJ (1998). Postnatal development of dopamine D4-like receptors in rat forebrain regions: Comparison with D2-like receptors. Brain Res Dev Brain Res 110:227-233.
119. Tarazi FI, Tomasini EC, Baldessarini RJ (1999). Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: An autoradiographic study. Dev Neurosci 21:43-49.
120. Teicher MH, Andersen SL, Hostetter JC (1995). Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Devl Brain Res 89:167-172.
121. Thiebot MH, Le Bihan C, Soubrié P, Simon P (1985). Benzodiazepines reduce the tolerance to reward delay in rats. Psychopharmacology (Berl) 86:147-152.
122. Tirelli E, Laviola G, Adriani W (2003). Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents. Neurosci Biobehav Rev 27:163-178.
123. Torabi MR, Bailey WJ, Majd-Jabbari M (1993). Cigarette smoking as a predictor of alcohol and other drug use by children and adolescents: Evidence of the 'gateway' drug effect. J Sch Health 63:302-306.
124. Trauth JA, Seidler FJ, McCook EC, Slotkin TA (1999). Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res 851:9-19.
125. Trauth JA, Seidler FJ, Ali SF, Slotkin TA (2001). Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. Brain Res 892:269-280.
126. Ueno KI, Togashi H, Mori K, Matsumoto M, Ohashi S, Hoshino A, et al. (2002). Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder. Behav Pharmacol 13:1-13.
127. Vaidya CJ, Austin G, Kirkorian G, et al. (1998). Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proc Natl Acad Sci U S A 95:14494-14495.
128. Valjent E, Maldonado R (2000). A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berl) 147: 436-438.
129. Vastola BJ, Douglas LA, Varlinskaya EI, Spear LP (2002). Nicotine-induced conditioned place preference in adolescent and adult rats. Physiol Behav 77:107-114.
130. Viggiano D, Grammatikopoulos G, Sadile AG (2002). A morphometric evidence for a hyperfunctioning mesolimbic system in an animal model of ADHD. Behav Brain Res 130:181-189.
131. Wade TR, De Wit H, Richards JB (2000). Effects of dopaminergic drugs on delayed reward as a measure of impulsive behaviour in rats. Psychopharmacology (Berl) 150:90-101.
132. Ward AS, Kelly TH, Foltin RW, Fischman MW (1997). Effects of D-amphetamine on task performance and social behaviour of humans in a residential laboratory. Exp Clin Psychopharmacol 5:130-136.
133. Wenger T, Moldrich G, Furst S (2003). Neuromorphological background of cannabis addiction. Brain Res Bull 61:125-128.
134. Wills TA, Sandy JM, Shinar O (1999). Cloninger's constructs related to substance use level and problems in late adolescence: A mediational model based on self-control and coping motives. Exp Clin Psychopharmacol 7:122-134.
135. Winder DG, Egli RE, Schramm NL, Matthews RT (2002). Synaptic plasticity in drug reward circuitry. Curr Mol Med 2:667-676.
136. Wise RA (1996). Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19:319-340.
137. Yamaguchi K, Kandel DB (1984). Patterns of drug use from adolescence to young adulthood. III. Predictors of progression. Am J Public Health 74:673-681.
138. Yang PB, Amini B, Swann AC, Dafny N (2003). Strain differences in the behavioural responses of male rats to chronically administered methylphenidate. Brain Res 971:139-152.